S100B and schizophrenia: Although there is controversy about the validity of S100B, an acidic calcium-binding protein secreted by astrocytes and oligodendrocytes, as a marker of BBB disruption [178], there have been reports of higher serum and CSF S100B concentrations in patients with schizophrenia compared to controls [179,180].